UnitedHealth Group's new CEO told investors that the company is reevaluating how it tallies Medicare Advantage patients' diagnoses for reimbursement purposes, an issue currently under investigation by DOJ. Stephen Hemsley's remarks during the company's annual shareholder meeting this week signal a noteworthy shift: UnitedHealth is now publicly acknowledging potential issues with how it assesses the health of its Medicare Advantage members.
